Ratings by Rodman & Renshaw
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | Michael King Jr. | Hemab Therapeutics Holdings | COAG | New Coverage | Buy (N/A) |
56.00 (N/A) |
31.62 (30.07) |
-4.9% | Details |
| 9/28/2026 | Michael King Jr. | Agenus Inc. | AGEN | New Coverage | Buy (N/A) |
19.00 (N/A) |
8.54 (6.04) |
-29.27% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 86 more... | |||||||||
